SCHEMBL11230459

SCHEMBL11230459

CCCCCc1cccc(C(=O)c2ccccc2)c1CCCCC

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BID P55957 3/20 0.48
MCL1 Q07820 3/20 0.48
PPARA Q07869 3/20 0.48
BCL2L1 Q07817 2/20 0.48
BAK1 Q16611 2/20 0.48
KAT8 Q9H7Z6 2/20 0.48
PPARG P37231 2/20 0.48
EP300 Q09472 1/20 0.48
KAT2A Q92830 1/20 0.48
KAT2B Q92831 1/20 0.48
KAT5 Q92993 1/20 0.48
SAE1 Q9UBE0 1/20 0.48
CYSLTR2 Q9NS75 6/20 0.44
CYSLTR1 Q9Y271 6/20 0.44
LIPG Q9Y5X9 1/20 0.44
CNR2 P34972 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2259745 0.95 AKR1C3 (0.43) BIDMCL1PPARABCL2L1BAK1
SCHEMBL10579965 0.91 AKR1C3 (0.42) PPARAPPARGCNR2
SCHEMBL11699273 0.88 CNR2 (0.43) BIDMCL1PPARABCL2L1BAK1
SCHEMBL3642864 0.88 BID (0.49) BIDMCL1PPARABCL2L1BAK1
SCHEMBL27304618 0.87 THRA (0.41) BIDMCL1PPARABCL2L1BAK1
SCHEMBL9559479 0.86 LIPG (0.51) BIDMCL1PPARABCL2L1BAK1
SCHEMBL1534314 0.86 LIPG (0.51) BIDMCL1PPARABCL2L1BAK1
SCHEMBL9626492 0.86 AKR1C3 (0.46) PPARAPPARG
SCHEMBL11002989 0.86 LIPG (0.51) BIDMCL1PPARABCL2L1BAK1
SCHEMBL31405271 0.86 LIPG (0.51) BIDMCL1PPARABCL2L1BAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240043688-A1 STABILIZED SILOXANE PARTICLES AND METHODS FOR MAKING AND USING THE SAME FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2024-02-08 US disclosed
US-20220168707-A1 ARTICLES COMPOSED OF ANHYDROUS POLYELECTROLYTE COMPLEXES AND THEIR USE AS DRYING AGENTS THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INCORPORATED 2022-06-02 US disclosed
US-10954183-B2 Curable composition, semi-cured product, cured product, optical member, lens, and compound FUJIFILM CORPORATION (JP) 2021-03-23 US disclosed
US-10919032-B2 Antifouling compositions and methods FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-02-16 US disclosed
US-10647953-B2 Surface treatment for cell culture The Florida State University Research Foundation, Inc. (US) 2020-05-12 US disclosed
US-20200115316-A1 CURABLE COMPOSITION, SEMI-CURED PRODUCT, CURED PRODUCT, OPTICAL MEMBER, LENS, AND COMPOUND FUJIFILM CORPORATION (JP) 2020-04-16 US disclosed
US-20190224664-A1 Antifouling Compositions and Methods UNIV FLORIDA STATE RES FOUND (US) 2019-07-25 US disclosed
US-10253203-B2 Rough polyelectrolyte complex coatings and methods of forming The Florida State University Research Foundation, Inc. (US) 2019-04-09 US disclosed
US-9919280-B2 Method of forming polyelectrolyte complex capsules The Florida State University Research Foundation, Inc. (US) 2018-03-20 US disclosed
US-20170204287-A1 ROUGH POLYELECTROLYTE COMPLEX COATINGS AND METHODS OF FORMING The Florida State University Research Foundation, Inc. 2017-07-20 US disclosed
US-20160230136-A1 SURFACE TREATMENT FOR CELL CULTURE The Florida State University Research Foundation, Inc. 2016-08-11 US disclosed
US-20160144328-A1 METHOD OF FORMING POLYELETROLYTE COMPLEX CAPSULES NATIONAL SCIENCE FOUNDATION 2016-05-26 US disclosed
WO-2015119891-A1 ROUGH POLYELECTROLYTE COMPLEX COATINGS AND METHODS OF FORMING FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2015-08-13 WO disclosed
US-20150104484-A1 STORED STRAIN POLYELECTROLYTE COMPLEXES AND METHODS OF FORMING NATIONAL SCIENCE FOUNDATION 2015-04-16 US disclosed
US-4347383-A BY REACTING BENZOPHENONE-IMINE WITH OXYGEN OR BENZOPHENONE WITH OXYGEN AND AMMONIA MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1982-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115316-A1 CURABLE COMPOSITION, SEMI-CURED PRODUCT, CURED PRODUCT, OPTICAL MEMBER, LENS, AND COMPOUND CRYAA, Q6ZSR9, CRYZ BID 4382/4885MCL1 2714/4885PPARA 4350/4885
US-10954183-B2 Curable composition, semi-cured product, cured product, optical member, lens, and compound CRYAA, Q6ZSR9, CRYZ BID 4382/4885MCL1 2714/4885PPARA 4350/4885
US-20150104484-A1 STORED STRAIN POLYELECTROLYTE COMPLEXES AND METHODS OF FORMING VCL, PARG, MYOC BID 4260/4885MCL1 2454/4885PPARA 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.